Operating Income (Loss) in USD of Surface Oncology, Inc. from 2016 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Surface Oncology, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2016 to Q2 2023.
  • Surface Oncology, Inc. Operating Income (Loss) for the quarter ending 30 Jun 2023 was -$25.6M, a 4.13% decline year-over-year.
  • Surface Oncology, Inc. Operating Income (Loss) for the twelve months ending 30 Jun 2023 was -$89.4M, a 47.4% decline year-over-year.
  • Surface Oncology, Inc. annual Operating Income (Loss) for 2022 was -$61.9M, a 18.6% increase from 2021.
  • Surface Oncology, Inc. annual Operating Income (Loss) for 2021 was -$76M, a 223% decline from 2020.
  • Surface Oncology, Inc. annual Operating Income (Loss) for 2020 was $61.6M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Surface Oncology, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$89.4M -$25.6M -$1.02M -4.13% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2023
Q1 2023 -$88.4M -$19.7M -$26.5M -388% 01 Jan 2023 31 Mar 2023 10-Q 04 May 2023
Q4 2022 -$61.9M -$21.2M +$2.19M +9.37% 01 Oct 2022 31 Dec 2022 8-K 03 Jul 2023
Q3 2022 -$64.1M -$22.9M -$3.41M -17.5% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2022
Q2 2022 -$60.7M -$24.6M -$6.04M -32.5% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023
Q1 2022 -$54.6M $6.84M +$21.4M 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 -$76M -$23.4M -$91.3M -134% 01 Oct 2021 31 Dec 2021 8-K 03 Jul 2023
Q3 2021 $15.3M -$19.5M -$5.13M -35.8% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $20.5M -$18.6M -$4.05M -27.8% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 $24.5M -$14.6M -$37.1M -165% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 $61.6M $68M +$84.3M 01 Oct 2020 31 Dec 2020 10-K 09 Mar 2021
Q3 2020 -$22.7M -$14.4M +$3.2M +18.2% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 -$25.9M -$14.5M +$3.97M +21.4% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 -$29.9M $22.5M +$27.5M 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 -$57.4M -$16.3M -$10.8M -193% 01 Oct 2019 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 -$46.6M -$17.6M +$474K +2.63% 01 Jul 2019 30 Sep 2019 10-K 09 Mar 2021
Q2 2019 -$47.1M -$18.5M -$1.93M -11.6% 01 Apr 2019 30 Jun 2019 10-K 09 Mar 2021
Q1 2019 -$45.2M -$4.97M -$36M -116% 01 Jan 2019 31 Mar 2019 10-K 09 Mar 2021
Q4 2018 -$9.15M -$5.58M +$11.1M +66.5% 01 Oct 2018 31 Dec 2018 10-K 10 Mar 2020
Q3 2018 -$20.2M -$18M -$3.76M -26.3% 01 Jul 2018 30 Sep 2018 10-K 10 Mar 2020
Q2 2018 -$16.4M -$16.6M -$10.1M -154% 01 Apr 2018 30 Jun 2018 10-K 10 Mar 2020
Q1 2018 -$6.39M $31M +$39.6M 01 Jan 2018 31 Mar 2018 10-K 10 Mar 2020
Q4 2017 -$46M -$16.6M 01 Oct 2017 31 Dec 2017 10-K 07 Mar 2019
Q3 2017 -$14.3M 01 Jul 2017 30 Sep 2017 10-K 07 Mar 2019
Q2 2017 -$6.53M 01 Apr 2017 30 Jun 2017 10-K 07 Mar 2019
Q1 2017 -$8.55M 01 Jan 2017 31 Mar 2017 10-K 07 Mar 2019

Surface Oncology, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$61.9M +$14.1M +18.6% 01 Jan 2022 31 Dec 2022 8-K 03 Jul 2023
2021 -$76M -$138M -223% 01 Jan 2021 31 Dec 2021 8-K 03 Jul 2023
2020 $61.6M +$119M 01 Jan 2020 31 Dec 2020 8-K 03 Jul 2023
2019 -$57.4M -$48.2M -527% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2022
2018 -$9.15M +$36.8M +80.1% 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2021
2017 -$46M -$28M -155% 01 Jan 2017 31 Dec 2017 10-K 10 Mar 2020
2016 -$18M 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.